{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:32:17Z","timestamp":1780345937060,"version":"3.54.1"},"reference-count":25,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medigen Vaccine Biologics Corporation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Enterovirus A71 (EV-A71) causes hand, foot, and mouth disease in infants and children with potential for fatal complications such as encephalitis and acute flaccid myelitis. This study examined the long-term immunity conferred by EV71vac, an inactivated EV-A71 vaccine adjuvanted with aluminum phosphate, in children from the age of 2 months to &lt;6 years, for up to 5 years after the first immunization. A total of 227 participants between 2 months and &lt;6 years of age who had previously received either EV71vac or placebo in the phase two clinical study were enrolled. Subjects were divided into age groups: 2 years to &lt;6 years (Group 2b), 6 months to &lt;2 years (Group 2c), and 2 months to &lt;6 months (Group 2d). At Year 5, the neutralizing antibody titers against the B4 subgenotype remained high at 621.38 to 978.20, 841.40 to 1159.93, and 477.71 to 745.07 for Groups 2b, 2c, and 2d, respectively. Cross-neutralizing titers at Year 5 remained high against B5 and C4a subgenotypes, respectively. No long-term safety issues were reported. Our study provides novel insights into the long-term immunity conferred by EV71vac in children aged from two months to six years, particularly in those who received EV71vac between two and six months of age.<\/jats:p>","DOI":"10.3390\/vaccines12090985","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:33:37Z","timestamp":1724931217000},"page":"985","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-Term Immunogenicity Study of an Aluminum Phosphate-Adjuvanted Inactivated Enterovirus A71 Vaccine in Children: An Extension to a Phase 2 Study"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3966-5021","authenticated-orcid":false,"given":"Nan-Chang","family":"Chiu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, MacKay Children\u2019s Hospital, Taipei 10449, Taiwan"},{"name":"Department of Medicine, Mackay Medical College, New Taipei City 25245, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yu","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mackay Medical College, New Taipei City 25245, Taiwan"},{"name":"Department of Pediatrics, Hsinchu Municipal MacKay Children\u2019s Hospital, Hsinchu City 300, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Chen","sequence":"additional","affiliation":[{"name":"Medigen Vaccine Biologics Corp., Taipei 11493, Taiwan"},{"name":"College of Science and Technology, Temple University, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yuan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Medigen Vaccine Biologics Corp., Taipei 11493, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erh-Fang","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Medigen Vaccine Biologics Corp., Taipei 11493, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke Tzu-Chi","family":"Liu","sequence":"additional","affiliation":[{"name":"Medigen Vaccine Biologics Corp., Taipei 11493, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan City 33305, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-260X","authenticated-orcid":false,"given":"Li-Min","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Taiwan University Children\u2019s Hospital, Taipei City 100226, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e2361","DOI":"10.1002\/rmv.2361","article-title":"Insight into the Enterovirus A71: A review","volume":"32","author":"Kinobe","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.meegid.2012.10.016","article-title":"Picornavirus and enterovirus diversity with associated human diseases","volume":"14","author":"Tapparel","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jiac.2022.12.006","article-title":"Analysis of the epidemiological trends of enterovirus A in Asia and Europe","volume":"29","author":"Qiao","year":"2023","journal-title":"J. Infect. Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Puenpa, J., Wanlapakorn, N., Vongpunsawad, S., and Poovorawan, Y. (2019). The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific Region. J. Biomed. Sci., 26.","DOI":"10.1186\/s12929-019-0573-2"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Li, M.L., Shih, S.R., Tolbert, B.S., and Brewer, G. (2021). Enterovirus A71 Vaccines. Vaccines, 9.","DOI":"10.3390\/vaccines9030199"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1016\/j.vaccine.2020.05.001","article-title":"WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines","volume":"38","author":"Lei","year":"2020","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.vaccine.2019.02.023","article-title":"Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan","volume":"37","author":"Huang","year":"2019","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/S0140-6736(22)00313-0","article-title":"Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: A multiregion, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"399","author":"Nguyen","year":"2022","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20200103","DOI":"10.1002\/VIW.20200103","article-title":"Longevity of vaccine protection: Immunological mechanism, assessment methods, and improving strategy","volume":"3","author":"Chen","year":"2022","journal-title":"View"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.immuni.2015.06.016","article-title":"Long-Lived Plasma Cells Are Contained within the CD19(\u2212)CD38(hi)CD138(+) Subset in Human Bone Marrow","volume":"43","author":"Halliley","year":"2015","journal-title":"Immunity"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hu, Y.L., Chen, C.M., Wang, E.T., Kuo, H.W., Shih, W.L., Fang, C.T., Liu, D.P., and Chang, L.Y. (2022). The secular trend of enterovirus A71 after the implementation of preventive measures in Taiwan. BMC Public Health, 22.","DOI":"10.1186\/s12889-022-13916-0"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chou, A.H., Liu, C.C., Chang, J.Y., Jiang, R., Hsieh, Y.C., Tsao, A., Wu, C.L., Huang, J.L., Fung, C.P., and Hsieh, S.M. (2013). Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079783"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1016\/j.vaccine.2012.09.030","article-title":"Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach","volume":"30","author":"Kirk","year":"2012","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3201\/eid2602.190721","article-title":"Neutralizing antibodies against enteroviruses in patients with hand, foot and mouth disease","volume":"26","author":"Nguyet","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1080\/21645515.2018.1442997","article-title":"Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation","volume":"14","author":"Hu","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(12)61764-4","article-title":"Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: A randomised, double-blind, placebo-controlled phase 2 clinical trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/infdis\/jiu113","article-title":"A booster dose of an inactivated enterovirus 71 vaccine in Chinese young children: A randomized, double-blind, placebo-controlled clinical trial","volume":"210","author":"Shenyu","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liu, L., Mo, Z., Liang, Z., Zhang, Y., Li, R., Ong, K.C., Wong, K.T., Yang, E., Che, Y., and Wang, J. (2015). Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: A report of further observations. BMC Med., 13.","DOI":"10.1186\/s12916-015-0448-7"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tan, X., Huang, X., Zhu, S., Chen, H., Yu, Q., Wang, H., Huo, X., Zhou, J., Wu, Y., and Yan, D. (2011). The persistent circulation of enterovirus 71 in People\u2019s Republic of China: Causing emerging nationwide epidemics since 2008. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025662"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2073","DOI":"10.1002\/rmv.2073","article-title":"Immune responses against enterovirus A71 infection: Implications for vaccine success","volume":"29","author":"NikNadia","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"ref_22","unstructured":"Taiwan Centers for Disease Control (2024, August 16). Enterovirus A71 Vaccine. Last Updated 6 July 2023, (In Chinese)."},{"key":"ref_23","unstructured":"Pediatric Infectious Diseases Society of Taiwan (2024, August 16). Recommendations for the Use of Enterovirus A71 Vaccine. Last Updated 20 June 2023. (In Chinese)."},{"key":"ref_24","unstructured":"CMMedia (2024, August 16). Enterovirus Infection Highest in 10 Years. Last Updated 7 May 2024. (In Chinese)."},{"key":"ref_25","unstructured":"World Health Organization (2021). Report of the Seventy-Second and Seventy-Third Meetings of the WHO Expert Committee on Biological Standardization Annex 3: Recommendations to Assure the Quality, Safety, and Efficacy of Enterovirus 71 Vaccine (Inactivated), World Health Organization. Available online: https:\/\/www.who.int\/publications\/m\/item\/ev71-recommendations."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/9\/985\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:45:04Z","timestamp":1760111104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/9\/985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["vaccines12090985"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12090985","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}